(-)-Bicuculline methiodide

Technical documents: SDS CoA Datasheet

Product overview

Name (-)-Bicuculline methiodide
Description Prototypic, competitive GABAA receptor antagonist
Alternative names BIC, BMI
Purity >98%
Customer comments

Good quality product: (-)-Bicuculline methiodide is used routinely in our lab for a number of experiments. It is shipped quickly, packaged well, dissolves without problem, and blocks GABAA-receptor activity as it should! Verified customer, Sickkids foundation

We routinely use this compound from Hello Bio to inhibit GABA-A receptors in electrophysiological recordings from rodent brain slices. Verified customer, University of Montana

Write Your Own Review
You're reviewing:(-)-Bicuculline methiodide
Rate this item:


Bicuculline inhibition of GABAA receptor mediated IPSCs
(-)-Bicuculline methiodide (batch E0868-2-1)
(-)-Bicuculline methiodide vial

Biological Data

Biological description

Methiodide salt form of (+)-bicuculline.

Prototypic, competitive GABAA receptor antagonist which displaces GABA from the agonist binding site to prevent receptor activation. 

Also acts as a negative allosteric inhibitor of channel opening to inhibit GABAA receptor activation by anaesthetic agents.

Additionally shows activity at SK calcium-activated potassium channels, nicotinic acetylcholine receptors and acetylcholinesterase.

Reversibly and competitively blocks GABAA receptor mediated currents. Widely used to isolate glutamate receptor mediated EPSCs (excitatory postsynaptic potentials).

Shows convulsant action and induces epilepsy.

Freebase, methochloride and methobromide salts also available.

Application notes

The GABAA receptor antagonist bicuculline is commonly used to reduce levels of inhibition by blocking the actions of the neurotransmitter GABA. Bicuculline is commonly used at concentrations of 100 μM and above.

Bicuculline methiodide from Hello Bio reduces both spontaneous inhibitory post synaptic currents (IPSC) and evoked IPSCs (see Fig 1 above). It was effective at concentrations of 1 mM with complete receptor blockade at 100 μM.


#Protocol 1: Evoked and spontaneous inhibitory post synaptic currents (IPSCs)

  • Whole cell voltage clamp recordings were obtained from layer V neurons of the mouse prelimbic cortex brain slice.
  • A stimulating electrode was placed in layers II/III and IPSCs were evoked by a single square (150 μs) pulse every 10 sec at a stimulus intensity that gave a reliable IPSC.
  • IPSCs were evoked at a range of neuron holding voltages to measure the reversal potential of the current to ensure it was GABAergic.
  • Neurons were held at 0mV and IPSCs continuously stimulated and recorded in response to 5 min applications of varying concentrations of Bicuculline methiodide until complete receptor inhibition.
  • Spontaneous IPSCs were recorded before and after addition of Bicuculline methiodide by holding the neuron at 0mV and recording for 10 sec.
  • All recordings for IPSCs were made in the presence of AMPAR antagonists.

Solubility & Handling

Storage instructions Room temperature
Solubility overview Soluble in water (20mM) or DMSO (50mM)
Handling This compound is light sensitive; exposure to light may affect compound performance. We therefore recommend storing the solid material and any solutions in the dark and protecting from light.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.



More Info


More Info

Chemical Data

Chemical name [R-(R*,S*)]-5-(6,8-Dihydro-8-oxofuro[3,4-e]-1,3-benzodioxol-6-yl)-5,6,7,8-tetrahydro-6,6-dimethyl-1,3-dioxolo[4,5-g]isoquinolinium iodide
Molecular Weight 509.3
Chemical structure (-)-Bicuculline methiodide  [40709-69-1] Chemical Structure
Molecular Formula C21H20INO6
CAS Number 40709-69-1
PubChem identifier 104871
SMILES C[N+]1(CCC2=CC3=C(C=C2C1C4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3)C.[I-]
Source Synthetic
InChi InChI=1S/C21H20NO6.HI/c1-22(2)6-5-11-7-15-16(26-9-25-15)8-13(11)18(22)19-12-3-4-14-20(27-10-24-14)17(12)21(23)28-19;/h3-4,7-8,18-19H,5-6,9-10H2,1-2H3;1H/q+1;/p-1/t18-,19+;/m0./s1
MDL number MFCD00078966
Appearance Yellow solid

References for (-)-Bicuculline methiodide

References are publications that support the biological activity of the product
  • Advantages of an antagonist: bicuculline and other GABA antagonists.

    Johnston GA (2013) Br J Pharmacol 169(2) : 328-36.
  • [Bicuculline inhibits airway remodeling in a murine model of chronic asthma].

    Zhu T et al (2010) Nan Fang Yi Ke Da Xue Xue Bao 30(4) : 842-6.
  • Differential effects of iontophoretic in vivo application of the GABA(A)-antagonists bicuculline and gabazine in sensory cortex.

    Kurt S et al (2006) Hear Res 212(1-2) : 224-35.
These publications cite the use of (-)-Bicuculline methiodide purchased from Hello Bio:
  • Serotonin 5-HT7 receptors require cyclin-dependent kinase 5 to rescue hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome

    Costa et al (2021) Eur J Neurosci. 5 : doi:10.1111/ejn.15246
    PubMedID: 33949019
  • Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses

    Maus et al. (2020) Cell Rep. 30(11) : 3632-3643
    PubMedID: 32187536
  • Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions.

    Gonatopoulos-Pournatzis et al. (2020) Mol Cell 77(6) : 1176-1192
    PubMedID: 31999954
  • Altered excitatory transmission onto hippocampal interneurons in the IQSEC2 mouse model of X-linked neurodevelopmental disease

    Sah M et al (2020) Neurobiol Dis 137 : 104758
    PubMedID: 31978606
  • Reduced GABAergic Neuron Excitability, Altered Synaptic Connectivity, and Seizures in a KCNT1 Gain-of-Function Mouse Model of Childhood Epilepsy

    Shore et al (2020) Cell Rep. 33(4) : 108303
    PubMedID: 33113364

Items 1 to 5 of 11 total